NCT03932760

Brief Summary

The goal of the project is to evaluate for the first time, the effectiveness of using a telehealth approach to reducing perinatal depressive symptoms in diverse groups of childbearing women; urban and rural-dwelling, and from Hispanic and predominantly North European Descent populations. Pregnant women connect for one hour weekly, for 8 weeks, using their own electronic device, from whatever location they choose (e.g. home), to attend videoconference groups facilitated by a mental health professional. The approach is cost effective and reduces barriers to access to mental health services, particularly for women living in rural, low-resource, and minority communities, and those without adequate transportation, financial resources, childcare, or work release time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 1, 2019

Completed
1 year until next milestone

Study Start

First participant enrolled

May 1, 2020

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

June 4, 2024

Completed
Last Updated

June 4, 2024

Status Verified

May 1, 2024

Enrollment Period

2.8 years

First QC Date

April 16, 2019

Results QC Date

August 23, 2023

Last Update Submit

May 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Depressive Symptoms Over Time

    Self-completed: Edinburgh Postnatal Depression Scale measures depression symptoms during pregnancy and postpartum. The instrument will measure depressive symptoms at 6 time points during pregnancy and postpartum. The instrument is on a scale of 0-30, with 0 indicating no symptoms, and 30 indicating the highest severity of symptoms. Scores \< 10 = no depressive symptoms; 10-15 = mild; 16-20 = moderate; \> 20 = severe.

    Time 1 = pre-intervention (Baseline); T2 = immediately following week 9 of group intervention classes (Post), T3= 2 months post-intervention; T4= 4 months post-intervention; T5 = 6 months post-intervention; T6 = 8 post-intervention

Secondary Outcomes (1)

  • Change in Anxiety Symptoms Over Time

    Time 1 = pre-intervention; T2 = immediately following week 9 of group intervention classes (post-intervention), T3= 2 months post-intervention; T4= 4 months post-intervention; T5 = 6 months post-intervention; T6 = 8 post-intervention

Study Arms (2)

UPLIFT Program

EXPERIMENTAL

Weekly one-hour group sessions for 10 weeks facilitated by a mental health professional.

Behavioral: UPLIFT Program

Pregnancy Skills Group

ACTIVE COMPARATOR

Weekly one-hour group sessions for 10 weeks facilitated by a registered nurse.

Behavioral: Attention Control Group

Interventions

UPLIFT ProgramBEHAVIORAL

UPLIFT is based on cognitive behavioral therapy and mindfulness-based practices. Participants meet by videoconference using any electronic device (laptop, tablet, smart phone) from their own home.

UPLIFT Program

Program is based on standard prenatal, childbirth, infant feeding, and parenting education curriculum. Participants meet by videoconference using any electronic device (laptop, tablet, smart phone) from their own home.

Pregnancy Skills Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant and postpartum women
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women age 18 and older
  • have a viable pregnancy (any gestational age) or postpartum (up to 6 months)
  • have an Edinburgh Postpartum Depression Scale (EPDS) score between 9 and 20
  • are English or Spanish speaking
  • are receiving clinical services at a collaborating prenatal or public health clinic associated with the U of Utah or Utah rural Health Districts

You may not qualify if:

  • women who have an EPDS score less than 9 or greater than 20
  • have a current diagnosis of a serious mental illness, such as psychosis, schizophrenia, bipolar disorder, severe depression, suicidal ideation, homicidal ideation
  • begun taking or changed dosage of any medications for a mental health condition within the previous 6 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah

Salt Lake City, Utah, 84112, United States

Location

Related Publications (1)

  • Iacob E, Kausler R, Williams M, Simonsen S, Smid M, Weissinger K, Latendresse G. Protocol for a randomized controlled trial to evaluate the effectiveness of a telehealth group intervention to reduce perinatal depressive symptoms. Contemp Clin Trials. 2024 Dec;147:107738. doi: 10.1016/j.cct.2024.107738. Epub 2024 Nov 13.

Limitations and Caveats

Limitations included low recruitment (largely due to COVID-19), difficulty in identifying participation in either group as the cause of lower EPDS scores 8 months after participation, and difficulty in accounting for factors impacting personal changes that can occur in the 10 months of involvement in the study.

Results Point of Contact

Title
Gwen Latendresse
Organization
University of Utah

Study Officials

  • Gwen Latendresse, PhD

    University of Utah

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assitant Dean, Associate Professor

Study Record Dates

First Submitted

April 16, 2019

First Posted

May 1, 2019

Study Start

May 1, 2020

Primary Completion

March 1, 2023

Study Completion

March 1, 2023

Last Updated

June 4, 2024

Results First Posted

June 4, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

The PI will share de-identified data to other investigators for study, including demographics, outcomes, communication methodology, and design. Data will be shared with investigators working under an institution with a Federal Wide Assurance (FWA) and can be used for secondary study purposes. The PI agrees to make available data within one year of the completion of the funded project period and manuscripts pertaining to the aims. The PI agrees to share data in a manner that is fully consistent with NIH data sharing policies and applicable laws and regulations.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
The PI agrees to make available data within one year of the completion of the funded project period
Access Criteria
Data will be shared with investigators working under an institution with a Federal Wide Assurance (FWA) and can be used for secondary study purposes.

Locations